Nomograms to estimate long-term overall survival and breast cancer-specific survival of patients with luminal breast cancer
暂无分享,去创建一个
Ding Ma | Wei Sun | Z. Shao | Yi-Zhou Jiang | Zhi-Ming Shao | Yirong Liu | Yi-Rong Liu | Yizhou Jiang | D. Ma | Wei-li Sun
[1] R Peto,et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials , 2011, The Lancet.
[2] A. Jemal,et al. Breast Cancer Statistics , 2013 .
[3] Jack Cuzick,et al. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. , 2010, The Lancet. Oncology.
[4] A. Kallioniemi,et al. The impact of lobular and ductal breast cancer histology on the metastatic behavior and long term survival of breast cancer patients. , 2013, Breast.
[5] J. Cunningham,et al. Racial disparities in female breast cancer in South Carolina: clinical evidence for a biological basis , 2004, Breast Cancer Research and Treatment.
[6] R. Salunga,et al. Gene expression profiles of human breast cancer progression , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[7] N. Sakamoto,et al. Population-based study evaluating and predicting the probability of death resulting from thyroid cancer and other causes among patients with thyroid cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] R. Gray. A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .
[9] Keda Yu,et al. Different Patterns in the Prognostic Value of Age for Breast Cancer-Specific Mortality Depending on Hormone Receptor Status: A SEER Population-Based Analysis , 2015, Annals of Surgical Oncology.
[10] C. Carter,et al. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases , 1989, Cancer.
[11] William A Ghali,et al. Kaplan-Meier methods yielded misleading results in competing risk scenarios. , 2006, Journal of clinical epidemiology.
[12] H. Putter,et al. Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer , 2012 .
[13] R. Gelber,et al. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[14] Robert Gray,et al. A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .
[15] J Crowley,et al. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. , 1999, Statistics in medicine.
[16] C. Desch,et al. The effect of age and comorbidity in the treatment of elderly women with nonmetastatic breast cancer. , 1996, Archives of internal medicine.
[17] L. Kao,et al. The Effect of Age on Race-Related Breast Cancer Survival Disparities , 2013, Annals of Surgical Oncology.
[18] Jack Cuzick,et al. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. , 2008, The Lancet. Oncology.
[19] Ewout W. Steyerberg,et al. Prognostic Models With Competing Risks: Methods and Application to Coronary Risk Prediction , 2009, Epidemiology.
[20] Patrick Neven,et al. Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up. , 2011, The Lancet. Oncology.
[21] Y. Qiao,et al. The Diverse Distribution of Risk Factors between Breast Cancer Subtypes of ER, PR and HER2: A 10-Year Retrospective Multi-Center Study in China , 2013, PloS one.
[22] Keda Yu,et al. Effect of large tumor size on cancer-specific mortality in node-negative breast cancer. , 2012, Mayo Clinic proceedings.
[23] F. Spyratos,et al. A nomogram to predict individual prognosis in node-negative breast carcinoma. , 2012, European journal of cancer.
[24] G. Hortobagyi,et al. Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] G. Colditz,et al. Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[27] Charles M. Perou,et al. Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer , 2009, Journal of the National Cancer Institute.
[28] Philip M. Long,et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[29] Donald E. Henson,et al. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases , 1989 .
[30] R. Rosenfeld,et al. Cases , 2010, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[31] Y Wang,et al. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.
[32] Ping Sun,et al. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. , 2015, JAMA.
[33] R. Orecchia. Breast cancer: Post-mastectomy radiotherapy reduces recurrence and mortality , 2014, Nature Reviews Clinical Oncology.